BMRA Biomerica, Inc: Rasio Nilai Pasar marang Nilai Buku

Lambang korporat lan logo Biomerica (BMRA)

The market-to-book value trend on the GURU.Markets temporary chart demonstrates the position of Biomerica, Inc. (BMRA), which is protected by patents for home gastrointestinal tests. The 2.25 mark serves as the current indicator as the company scales retail sales of its diagnostics. The business's success is based on the qualifications of its biochemists, who foster a culture of scientific precision and high-quality research.

Biomerica Inc (BMRA) - Koefisien Nilai Pasar marang Nilai Buku saka 04.07.2022 nganti 29.10.2026
Barang unggulan Biomerica, Inc

This indicator determines the market value of assets relative to their book value, measuring the premium for future growth. For Biomerica, Inc. (BMRA), with its outsourcing model for production and IT infrastructure, this ratio reflects the value of intangible advantages. By analyzing the market cap to book capitalization multiple, an investor can track the dynamics of market confidence in the business model. A decline in this metric signals either undervaluation or a systemic crisis.

Analisis pesaing

A: Rasio Kapitalisasi Pasar marang Nilai Buku|questdiagnostics.com (DGX) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Illumina|Rasio Kapitalisasi marang Aset Bersih Exact Sciences Corp (EXAS)|Rasio Kapitalisasi Pasar marang Nilai Buku RVTY|BIO - Koefisien Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku NNNN (Anbio Biotechnology)|SHC: Rasio Kapitalisasi marang Nilai Buku|QuidelOrtho Corporation - Rasio Kapitalisasi Pasar marang Nilai Buku|OPK - Rasio Kapitalisasi Pasar marang Nilai Buku|CareDx (CDNA) - Rasio Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi marang Nilai Buku MRVI|FLGT (Fulgent Genetics, Inc.) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku fluidigm.com|Rasio Nilai Pasar marang Nilai Buku Cytek Biosciences (CTKB)|Rasio Nilai Pasar marang Nilai Buku OSUR (OraSure Technologies, Inc.)|Exagen - Rasio Kapitalisasi marang Aset Bersih|MDxHealth, Inc. (MDXH) - Koefisien Nilai Pasar marang Nilai Buku|LUCD - Rasio Nilai Pasar marang Nilai Buku|Kapitalisasi Pasar marang Nilai Buku Prenetics Global PRE|IMDX: Rasio Kapitalisasi Pasar marang Nilai Buku|TRIB - Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku ProPhase|Ainos Corporation (AIMD) - Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku CODX|Rasio Nilai Pasar marang Nilai Buku HSCS (heartsciences.com)|Rasio Kapitalisasi Pasar marang Nilai Buku CDIO (Cardio Diagnostics Holdings)|Kapitalisasi Pasar marang Nilai Buku Virax Biolabs Group Limited (VRAX)|BJDX - Rasio Nilai Pasar marang Nilai Buku|Koefisien Nilai Pasar marang Nilai Buku Aspira Women's Health Inc|Accelerate Diagnostics (AXDX) - Rasio Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi marang Aset Bersih CENTOGENE|ENZ (Enzo Biochem Inc.) - Rasio Kapitalisasi Pasar marang Nilai Buku|Koefisien Nilai Pasar marang Nilai Buku Fresh2 FRES|Rasio Nilai Pasar marang Nilai Buku Genetic Technologies (GENE)|ME (23andMe Inc) - Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku PMD (Psychemedics)